Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 201,000.00 KRW | -0.50% |
|
+0.85% | +16.60% |
| 08-04 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 07-24 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
| Market Cap | 46,095B 32.54B 28.12B 26.46B 24.06B 45.13B 3,105B 45.91B 310B 121B 1,556B 122B 120B 5,198B | P/E 2026 * |
30.6x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 48.07B 33.94M 29.32M 27.59M 25.09M 47.06M 3.24B 47.88M 323M 126M 1.62B 127M 125M 5.42B | EV / Sales 2026 * |
8.82x | EV / Sales 2027 * | 7.49x |
| Free-Float |
58.26% | Yield 2026 * |
0.38% | Yield 2027 * | 0.41% |
| 1 day | -0.50% | ||
| 1 week | +0.85% | ||
| Current month | +7.66% | ||
| 1 month | +14.40% | ||
| 3 months | +11.78% | ||
| 6 months | -11.32% | ||
| Current year | +16.60% |
| 1 week | 194,850 |  | 212,000 |
| 1 month | 168,200 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 A | Sell | 500 | 0.0002% | |||
| 1/16/26 A | Sell | 1,000 | 0.0004% | |||
| 1/16/26 A | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| -2.59% | -0.83% | -7.22% | -37.03% | 12.59B | |
| Average | -0.86% | +0.36% | +68.55% | +94.08% | 27.57B | |
| Weighted average by Cap. | -0.99% | +0.53% | +90.83% | +124.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,449B 3.85B 3.32B 3.13B 2.84B 5.33B 367B 5.43B 36.63B 14.31B 184B 14.44B 14.13B 615B | 6,325B 4.47B 3.86B 3.63B 3.3B 6.19B 426B 6.3B 42.51B 16.62B 214B 16.76B 16.4B 713B |
| Net income | 1,485B 1.05B 906M 853M 775M 1.45B 100B 1.48B 9.98B 3.9B 50.15B 3.94B 3.85B 168B | 1,768B 1.25B 1.08B 1.01B 923M 1.73B 119B 1.76B 11.89B 4.65B 59.71B 4.69B 4.58B 199B |
| Net Debt | 1,978B 1.4B 1.21B 1.14B 1.03B 1.94B 133B 1.97B 13.29B 5.2B 66.78B 5.24B 5.13B 223B | 1,262B 891M 770M 725M 659M 1.24B 85.04B 1.26B 8.49B 3.32B 42.63B 3.35B 3.27B 142B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | ₩201,000.00 | -0.50% | 341,446 |
| 13/08/26 | ₩202,000.00 | 0.00% | 679,170 |
| 12/08/26 | ₩202,000.00 | -4.04% | 926,438 |
| 11/08/26 | ₩210,500.00 | +4.73% | 886,325 |
| 10/08/26 | ₩201,000.00 | +0.85% | 533,999 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
